A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT03392428 · COMPLETED

Trial details

NCT number: NCT03392428
Sponsor: Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer of the Prostate Metastatic Cancer

Start date: 2018-01-29
Primary completion: 2019-12-31
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.